Latest Articles

Publication Date
Dienogest treatment of symptomatic adenomyosis: An in-depth meta-analysis.

Adenomyosis is a common gynecological disease and a major contributor to dysmenorrhea that substantially reduces the quality of life of the affected. Dienogest has emerged as a promising drug for …

Published: Dec. 30, 2024, midnight
Surface Molecular Markers for the Isolation of Viable Fibroblast Subpopulations in the Female Reproductive Tract: A Comprehensive Review.

Advancements in single-cell analyzis technologies, particularly single-cell RNA sequencing (scRNA-seq) and Fluorescence-Activated Cell Sorting (FACS), have enabled the analyzis of cellular diversity by providing resolutions that were not available previously. …

Published: Dec. 30, 2024, midnight
The Role of Inflammatory Markers NLR and PLR in Predicting Pelvic Pain in Endometriosis.

Background/Objectives: Chronic inflammation plays a critical role in pelvic pain among endometriosis patients. This study examines the association between inflammatory markers-specifically the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR)-and pelvic …

Published: Dec. 30, 2024, midnight
Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results for Endometriosis Diagnostic Blood Test - ABN Newswire

Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results for Endometriosis Diagnostic Blood Test ABN Newswire

Published: Dec. 29, 2024, 10:22 p.m.
Proteomics International’s PromarkerEndo Set to Revolutionize Endometriosis Diagnosis - TipRanks

Proteomics International’s PromarkerEndo Set to Revolutionize Endometriosis Diagnosis TipRanks

Published: Dec. 29, 2024, 9:48 p.m.
Pfizer faces possible class action after contraceptive Depo-Provera linked to brain tumours - ABC News

Pfizer faces possible class action after contraceptive Depo-Provera linked to brain tumours ABC News

Published: Dec. 29, 2024, 6:31 p.m.
Push for up to 10 extra days of paid leave for reproductive health - MSN

Push for up to 10 extra days of paid leave for reproductive health MSN

Published: Dec. 29, 2024, 12:55 a.m.
Endometriosis treatment - Press TV

Endometriosis treatment Press TV

Published: Dec. 28, 2024, 3 p.m.
Endometriosis Treatment - Press TV

Endometriosis Treatment Press TV

Published: Dec. 28, 2024, 2:39 p.m.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …

Published: Dec. 28, 2024, 12:47 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!